Glaukos Corporation

Glaukos Corporation

Medical Devices, 230 3rd Ave Ste 26, Aliso Viejo, California, 02451, United States, 501-1000 Employees

glaukos.com

  • facebook
  • twitter
  • LinkedIn

Who is GLAUKOS CORPORATION

At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseasestherapies that advance...

Read More

map
  • 230 3rd Ave Ste 26, Aliso Viejo, California, 02451, United States Headquarters: 230 3rd Ave Ste 26, Aliso Viejo, California, 02451, United States
  • 1998 Date Founded: 1998
  • 501-1000 Employees: 501-1000
  • dollar-icon Revenue: $50 Million to $100 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from GLAUKOS CORPORATION

Glaukos Corporation Org Chart and Mapping

Employees

Christina Kelley

Patient Services Case Manager

Erick Gordon

Lead, Shipping and Receiving

Karanvir Grewal

Sr. Quality Software Engineer

Thomas Webb

Senior Director, U.S. Commercial

Lori Pinski

Senior Regional Business Manager

Michael Rivera

Senior Product Marketing Manager

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Glaukos Corporation

Answer: Glaukos Corporation's headquarters are located at 230 3rd Ave Ste 26, Aliso Viejo, California, 02451, United States

Answer: Glaukos Corporation's official website is https://glaukos.com

Answer: Glaukos Corporation's revenue is $50 Million to $100 Million

Answer: Glaukos Corporation's SIC: 2834

Answer: Glaukos Corporation's NAICS: 325412

Answer: Glaukos Corporation has 501-1000 employees

Answer: Glaukos Corporation is in Medical Devices

Answer: Glaukos Corporation contact info: Phone number: Website: https://glaukos.com

Answer: At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseasestherapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access